Recent Episodes
✨
Protein biologics show promise for inflammatory and degenerative eye conditions.
✨
Nanoparticle vaccines show potential against a 'tripledemic'.
✨
Experts warn of denied access to personalized cancer care.
✨
AI is revolutionizing clinical development and drug timelines.
✨
New research links factors to heart disease, lung disease, and cancer risks.
✨
Wegovy pill shows significant weight loss potential (17%).
✨
AdipoPharma develops new metabolic disease treatments targeting insulin resistance.
✨
Anti-IL-1β drugs show potential to prevent lung cancer.
✨
A cancer drug demonstrated significant tumor reduction (up to 55%).
✨
K36 Therapeutics develops novel NSD2 inhibitors for multiple myeloma.
✨
UK group accelerates Ebolavirus vaccine development efforts.
✨
European patients face barriers to accessing treatments.
✨
UK is advancing in radiopharmaceutical development and investment.
✨
New treatment pathways discovered for difficult-to-treat breast cancers.
✨
FDA advances initiative for real-time clinical trial implementation.
✨
Outrun Therapeutics specializes in protein stabilization for cancer treatment.
✨
UK attracts investment and implements clinical trial reforms.
✨
Obesity drug improves liver health independent of weight loss.
✨
LabGenius uses AI and robotics to design novel cancer therapies.
✨
Key breakthroughs emerge from recent cancer research studies.